The excitement at SCDM 2023 was undeniable, and we were thrilled by the overwhelming response. Attendees gained invaluable insights into the evolving landscape of clinical data management and decentralized clinical trials. Our AI-driven data analytics platform sparked engaging conversations at the booth, further reinforcing the cutting-edge innovation MaxisIT brings to clinical research.
We are excited to share an exclusive recording of a standout case study from Johnson & Johnson Vision Care. This presentation, titled “Optimizing Study Cycle-time via Clinical Data Value Stream Automation,” tackles one of the most persistent challenges in clinical trials—lengthy study cycle times. Managing vast amounts of data and navigating complex processes often leads to delays that can impact timelines and decision-making.
This case study provides a real-world business overview, showcasing how MaxisIT’s platform addresses these challenges. By automating the clinical data value stream—from data management through to clinical reporting—our platform enables key teams to gain timely insights and make more informed, effective decisions, leading to significant cycle-time optimization.
Don’t miss the opportunity to learn how MaxisIT’s cutting-edge platform transformed Johnson & Johnson Vision Care’s study cycle time and empowered their data management and reporting teams. Register now to watch this exclusive presentation and discover how you can optimize your own clinical trials through data value stream automation!
Fill out the form below to watch the recording of this webinar
MaxisIT helps pharmaceutical and biopharmaceutical companies of all sizes plan and execute effective clinical trials. Our source-agnostic integrated clinical data analytics platform unifies data across clinical systems and CROs to enable real-time monitoring and on-time insights.